Eli Lilly to Expand API’s Plant Boosting Diabetes and Obesity Drugs Manufacturing in Indiana, USA
Eli Lilly and Company has announced that it has more than doubled its investment in its Lebanon, Indiana, USA manufacturing
Read moreEli Lilly and Company has announced that it has more than doubled its investment in its Lebanon, Indiana, USA manufacturing
Read moreIn a strategic move to bolster its global supply of antibody-drug conjugates (ADCs), AstraZeneca has announced the development of a
Read moreThe Behring Campus Eystrup is a cutting-edge research facility specialising in animal immunology, antibody development, and preclinical research. Located at
Read moreMerck KGaA (Merck) announced an investment today of more than €300 Million ($320.8m) in a new Life Science Research Centre
Read moreNovo Nordisk, a global pharmaceutical leader, has set in motion an extensive expansion project for its production facility in Chartres,
Read moreVarda Space Industries, a California-based startup, is venturing into the realm of pharmaceutical manufacturing in microgravity with the goal of
Read moreTakeda plans to invest approximately 100 Billion Yen ( 762,330,000 Million USD) to construct a new manufacturing plant for plasma-derived
Read moreWuXi STA, a subsidiary of WuXi AppTec, opened the doors of its first pharmaceutical product Continuous Manufacturing (CM) line for
Read moreThe construction of BioNTech’s first in-house plasmid DNA processing plant in Marburg, Germany, has now been completed, the company announced
Read moreThe opening of Catalent’s new ultra-modern, commercial-scale plasmid DNA (pDNA) manufacturing facility in Gosselies, Belgium was announced on the 26th
Read more